HR 3955
RAPID Reserve Act
Jurisdiction
US Congress
Session
119th Congress (2025-2026)
Last updated at
Jun 13, 2026, 4:11 PM
Take action
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Bill overview
The RAPID Reserve Act aims to strengthen the United States’ drug supply chain by creating a system for establishing and maintaining reserves of critical drugs and their active pharmaceutical ingredients. The bill directs the Department of Health and Human Services to award contracts to eligible entities – manufacturers, distributors, or wholesalers – to hold these reserves, ensuring a supply during shortages or public health emergencies. It also outlines guidelines for selecting vulnerable drugs, establishing reserve requirements, and prioritizing domestic manufacturing capacity, while potentially supporting the construction of new facilities to bolster the supply chain.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsor
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.